Hansoh Pharma

Company

Hansoh Pharma develops one asset, in phase 2 (obuprazine in schizophrenia). Mostly small molecule.

1
Asset
Furthest stage
Phase 2
0
Trials
2
Signals

Pipeline

1
  • obuprazine

    Phase 2, Small molecule, schizophrenia, Partner

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals2
  • Similar companies6

Intelligence